Cargando…
Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy
Osteoarthritis (OA) is a progressive and degenerative disease, which is no longer confined to the elderly. So far, current treatments are limited to symptom relief, and no valid OA disease-modifying drugs are available. Additionally, OA relative joint is challenging for drug delivery, since the drug...
Autores principales: | Kou, Longfa, Xiao, Shuyi, Sun, Rui, Bao, Shihui, Yao, Qing, Chen, Ruijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758706/ https://www.ncbi.nlm.nih.gov/pubmed/31524006 http://dx.doi.org/10.1080/10717544.2019.1660434 |
Ejemplares similares
-
Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage
por: Huang, Huirong, et al.
Publicado: (2022) -
OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential
impact of the polyethylene glycol linker size on drug delivery in vitro,
in situ, and in vivo
por: Kou, Longfa, et al.
Publicado: (2020) -
Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
por: Yao, Qing, et al.
Publicado: (2020) -
Intra-Articular Drug Delivery for Osteoarthritis Treatment
por: Cao, Yifeng, et al.
Publicado: (2021) -
Drug discovery and formulation development for acute pancreatitis
por: Jiang, Xue, et al.
Publicado: (2020)